BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23665062)

  • 41. [Vascular tumours and malformations, classification, pathology and imaging].
    Wassef M; Vanwijck R; Clapuyt P; Boon L; Magalon G
    Ann Chir Plast Esthet; 2006; 51(4-5):263-81. PubMed ID: 17005309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laser treatment in the management of infantile hemangiomas and capillary vascular malformations.
    Brauer JA; Geronemus RG
    Tech Vasc Interv Radiol; 2013 Mar; 16(1):51-4. PubMed ID: 23499132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
    Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
    Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A fraction of deep vascular birthmarks are true deep hemangiomas of infancy.
    Lee SJ; Shin DJ; Kim HY; Lee WJ; Kim DW; Chung HY; Baik SK; Lee JM; Huh S; Yoon GS
    Int J Dermatol; 2009 Aug; 48(8):817-21. PubMed ID: 19659859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular anomalies: differential diagnosis and mimickers.
    Garzon MC; Weitz N; Powell J
    Semin Cutan Med Surg; 2016 Sep; 35(3):170-6. PubMed ID: 27607326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 47. Coagulation issues in vascular anomalies.
    Ricci KW; Brandão LR
    Semin Pediatr Surg; 2020 Oct; 29(5):150966. PubMed ID: 33069295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The expression and role of glucose transporter-1 in infantile hemangioma].
    Yuan SM; Jiang HQ; Hong ZJ; Wang J; Hu XB; Ouyang TX; Xing X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Mar; 23(2):90-3. PubMed ID: 17554865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular birthmarks.
    Willenberg T; Baumgartner I
    Vasa; 2008 Feb; 37(1):5-17. PubMed ID: 18512538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Verrucous hemangioma revisited.
    Tennant LB; Mulliken JB; Perez-Atayde AR; Kozakewich HP
    Pediatr Dermatol; 2006; 23(3):208-15. PubMed ID: 16780464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment guideline for hemangiomas and vascular malformations of the head and neck.
    Zheng JW; Zhou Q; Yang XJ; Wang YA; Fan XD; Zhou GY; Zhang ZY; Suen JY
    Head Neck; 2010 Aug; 32(8):1088-98. PubMed ID: 19924783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Differential expression of CD133, Glut-1 in tissues and endothelial cells derived from infantile hemangioma and vascular malformation].
    Li N; Wang YR; Zhong AM; Wang WJ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Jul; 23(4):324-7. PubMed ID: 17926859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiepileptic Treatment Strategy in Vascular Malformations.
    Giakoumettis D; Margetis K; Stranjalis G; Haliasos N; Papaioannou TG; Themistocleous MS
    Curr Pharm Des; 2017; 23(42):6454-6463. PubMed ID: 29076420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.
    del Pozo J; López-Gutiérrez JC; Gómez-Tellado M; Nistal M; Soler R; Sacristán F; Tovar JA
    Pediatr Dermatol; 2011; 28(4):439-43. PubMed ID: 20403115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of vascular malformations and hemangiomas of the head and neck--an update.
    Eivazi B; Werner JA
    Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):157-63. PubMed ID: 23486379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular pathogenesis of vascular anomalies: classification into three categories based upon clinical and biochemical characteristics.
    Chiller KG; Frieden IJ; Arbiser JL
    Lymphat Res Biol; 2003; 1(4):267-81. PubMed ID: 15624555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laser Treatment of Vascular Anomalies.
    DeHart AN; Richter GT
    Dermatol Clin; 2022 Oct; 40(4):481-487. PubMed ID: 36243435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vascular anomalies: information documents].
    Philandrianos C; Degardin N; Casanova D; Bardot J; Petit P; Bartoli JM; Magalon G
    Ann Chir Plast Esthet; 2011 Jun; 56(3):254-64. PubMed ID: 20598795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three-dimensional CT angiography imaging of vascular tumors of the head and neck.
    Perkins JA; Sidhu M; Manning SC; Ghioni V; Sze R
    Int J Pediatr Otorhinolaryngol; 2005 Mar; 69(3):319-25. PubMed ID: 15733590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinicopathological reappraisal of orbital vascular malformations and distinctive GJA4 mutation in cavernous venous malformations.
    Chen KH; Huang HY; Chen TC; Liu YJ; Lin IC; Ng KF; Chuang HC; Huang SC
    Hum Pathol; 2022 Dec; 130():79-87. PubMed ID: 36209871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.